Ryan Williams: This Article Brings to Light The Complexity of PRP…
Ryan Williams, Physician Assistant at BHS Orthopedic Associates, shared on LinkedIn about a recent article by Benjamin B. Rothrauff et al, published in The American Journal of Sports Medicine:
”This article brings to light the complexity of PRP on more than the most popular topic, platelet dose.
The authors highlight patient specific impact, biologic composition, preparation, activation, ability to store PRP for future use, allogenic vs. autologous PRP, EVs, and peri-procedure optimization.
Practically, variables that can be impacted are:
1. Optimize the patient (address comorbidities, nutrition, exercise, sleep, and stress).
2. Have a consistent, high quality PRP protocol.
3. Use safe, quality, and value-based energy (not mentioned in the article), exercise (BFR), pharmaceutical and nutraceutical tools to enhance the patient and the composition of the PRP.
I’m curious of others real-world experience with pre-blood draw exercise and BFR, using a senolytic (dasatinib and quercetin, fisetin, astragalus/TA-65, etc.) or losartan (or any ARB) and any other optimization strategies.
I’ve had some patients inquire about optimizing their PRP with exercise and supplements.
I’ve had several ask about red/NIR light therapy which I encourage them to do before the procedure and continue after if they have already purchased a device (this was not mentioned in the article). ”
Title: Platelet-Rich Plasma in the Treatment of Musculoskeletal Disease in 2025 and Beyond
Authors: Benjamin B. Rothrauff, Joseph T. Featherall, Tyler J. Uppstrom, Greta Gohring, Anna-Laura Nelson, Thos A. Evans, Peter J. Millett, Matthew T. Provencher, Marc J. Philippon, Johnny Huard
Read the Full Article on The American Journal of Sports Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’